Chapter 13. Chemotherapy of Advanced Colorectal Cancer
- John H. Scholefield1,
- Axel Grothey2,
- Herand Abcarian3 and
- Tim Maughan4
Published Online: 14 JAN 2008
Copyright © 2006 by Blackwell Publishing Ltd
Challenges in Colorectal Cancer
How to Cite
Grothey, A. (2006) Chemotherapy of Advanced Colorectal Cancer, in Challenges in Colorectal Cancer (eds J. H. Scholefield, A. Grothey, H. Abcarian and T. Maughan), Blackwell Publishing Ltd, Malden, Massachusetts, USA. doi: 10.1002/9780470753231.ch13
Professor of Surgery, University Hospital, Nottingham, UK
Professor, Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA
Turi Josefsen Professor and Chairman, Department of Surgery, University of Illinois College of Medicine, Chicago, Illinois, USA
Professor of Cancer Studies, University of Cardiff, Cardiff, UK
- Published Online: 14 JAN 2008
- Published Print: 1 JAN 2006
Print ISBN: 9781405127066
Online ISBN: 9780470753231
- colorectal cancer;
This chapter contains section titled:
What is the best sequence of chemotherapy options?
Can oral 5-FU prodrugs serve as substitute for infusional 5-FU in modern combination regimens?
Should a biologic agent be added upfront?
How long should first-line treatment be continued?
Can patients with metastatic disease be candidates for a curative approach?
Summary and conclusion